Introduction

The human liver serves as the body's ultimate metabolic and detoxification engine. Historically, in vitro hepatic modeling has been plagued by a major roadblock: primary hepatocytes rapidly lose their structural polarity and vital drug-metabolizing enzymes within days of being plated in 2D cultures. Creative Biolabs engineers highly specialized reagent ecosystems designed to construct, differentiate, and sustain robust 3D liver organoids that retain true in vivo functionality.

By delivering the precise biochemical nutrients and architectural support required for hepatic self-organization, our solutions allow researchers to maintain functional hepatocytes and cholangiocytes over extended culture periods.

Contact with our liver tissue specialists today to build a robust culture framework and request a laboratory-specific quotation designed to advance your hepatology research.

Solving the Hepatic Dedifferentiation Challenge

Generating a predictive liver model requires overcoming the rapid loss of phenotype that occurs outside the body. Whether you are expanding adult stem cells or differentiating hiPSCs, our media formulations directly target the fundamental pain points of hepatic biology:

The Creative Biolabs Benchmark for Liver Models

Targeted Reagent Suites for Hepatic Workflows

We provide a comprehensive catalog of reagents tailored to the distinct cellular lineages of the liver:

• 1. Hepatic Progenitor Expansion Media A highly potent, growth-factor-rich formulation designed for the rapid, long-term expansion of ductal stem cells and hepatic progenitors without triggering premature senescence or unwanted differentiation.
• 2. Hepatocyte Maturation Cocktails A specialized, serum-free differentiation medium that downregulates proliferation signals and drives progenitors to adopt a mature hepatocyte fate, restoring adult-level metabolic and synthetic functions.
• 3. Cholangiocyte (Biliary) Differentiation Kits For researchers focusing on the biliary tree, this targeted media kit specifically induces the formation of functional, fluid-secreting cystic cholangiocyte organoids, perfect for modeling ductal diseases.
• 4. 3D Liver-Specific Scaffolding Solutions Move beyond generic basement membrane extracts. We offer finely tuned hydrogels that replicate the unique biochemical stiffness and laminin/collagen ratios of healthy or fibrotic human liver tissue.

Empowering Hepatology and Toxicology

Our hepatic reagents are rigorously validated to support the most demanding preclinical applications:

• Drug-Induced Liver Injury (DILI): Perform highly accurate, long-term predictive toxicology and safety pharmacology screens using metabolically competent cells.
• Metabolic Syndrome Modeling: Replicate the pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH by challenging our mature organoids with free fatty acid supplements.
• Infectious Disease Research: Maintain stable host models for the study of hepatotropic viruses (such as HBV and HCV) or malaria parasites.

Fig.1 Morphology of cultured hepatocyte systems.¹

FAQs

• 1. How do you verify the functional maturity of liver organoids grown in your media?
  We validate our maturation media by measuring sustained albumin secretion, urea production, and the basal/inducible activity of key metabolizing enzymes like CYP3A4, CYP1A2, and CYP2C9 using standard fluorometric assays.
• 2. Can I use these reagents to model NAFLD or liver fibrosis?
  Yes. Our chemically defined maturation media provide a clean, lipid-free baseline. You can easily supplement this media with your own fatty acid cocktails (like oleic/palmitic acid) to reliably induce steatosis and study fibrotic progression.
• 3. Do your expansion media support patient-derived hepatocellular carcinoma (HCC) tumoroids?
  Absolutely. Our expansion formulations are highly effective for establishing and banking primary liver tumoroids, allowing you to preserve the genetic and phenotypic heterogeneity of the original patient tumor for downstream drug screening.

How to Contact Us

Your hepatology research relies heavily on the metabolic competence of your in vitro models. Don't compromise your data with generic media that allow your cells to dedifferentiate. Partner with Creative Biolabs to cultivate highly functional, long-lasting liver organoids that deliver the physiological accuracy your pharmacology and toxicology assays demand.

To explore specific protocol adaptations, discuss your drug screening requirements, or request a custom pricing package, please reach out to our scientific team at or dial +1-631-357-2254 today.

Contact Us

Reference

1. Lee, Ji-Young et al. "Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis" International journal of molecular sciences vol. 21,8 2982. 23 Apr. 2020. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms21082982

For Research Use Only. Not For Clinical Use.